These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


501 related items for PubMed ID: 26452045

  • 21. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.
    Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E.
    Am J Perinatol; 2010 May; 27(5):381-6. PubMed ID: 20013606
    [Abstract] [Full Text] [Related]

  • 22. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P, Khositseth A, Thanomsingh P.
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [Abstract] [Full Text] [Related]

  • 23. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A, Johansson S, Håkansson S, Norman M, Källen K, Bonamy AK.
    Neonatology; 2015 Feb; 107(2):87-92. PubMed ID: 25412681
    [Abstract] [Full Text] [Related]

  • 24. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
    Woynarowska M, Rutkowska M, Szamotulska K.
    Med Wieku Rozwoj; 2008 Feb; 12(4 Pt 1):933-41. PubMed ID: 19471069
    [Abstract] [Full Text] [Related]

  • 25. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
    Montgomery AM, Bazzy-Asaad A, Asnes JD, Bizzarro MJ, Ehrenkranz RA, Weismann CG.
    Neonatology; 2016 Feb; 109(3):190-4. PubMed ID: 26780635
    [Abstract] [Full Text] [Related]

  • 26. Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.
    Fritz AS, Keller T, Kribs A, Hünseler C.
    Eur J Pediatr; 2021 Apr; 180(4):1193-1201. PubMed ID: 33141298
    [Abstract] [Full Text] [Related]

  • 27. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M.
    Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
    [Abstract] [Full Text] [Related]

  • 28. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.
    Khan SS, Sithisarn T, Bada HS, Vranicar M, Westgate PM, Hanna M.
    J Perinatol; 2017 Dec; 37(12):1319-1324. PubMed ID: 28906496
    [Abstract] [Full Text] [Related]

  • 29. Patent ductus arteriosus and the association between lung ultrasound score and bronchopulmonary dysplasia: a secondary analysis of a prospective study.
    Li Z, Mu X, Lv X, Guo Y, Si S, Wu H.
    Eur J Pediatr; 2024 Oct; 183(10):4309-4317. PubMed ID: 39073470
    [Abstract] [Full Text] [Related]

  • 30. Development of a Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia or Death: Role of N-Terminal Pro-brain Natriuretic Peptide as a Biomarker.
    Song M, Lei M, Luo C, Shi Z, Cheng X, Ding W, Cao W, Zhang J, Ge J, Wang M, Xia P, Mao F, Wang L, Zhang Q.
    Front Pediatr; 2021 Oct; 9():727362. PubMed ID: 34497786
    [Abstract] [Full Text] [Related]

  • 31. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y, Zhang H, Zhao Z, Du J, Bai R, McNamara PJ.
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [Abstract] [Full Text] [Related]

  • 32. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
    Rodriguez-Blanco S, Oulego-Erroz I, Gautreaux-Minaya S, Perez-Muñuzuri A, Couce-Pico ML.
    J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. NT-proBNP as an Early Marker of Diastolic Ventricular Dysfunction in Very-Low-Birth-Weight Infants.
    Zafra-Rodríguez P, Méndez-Abad P, Lubián-López SP, Benavente-Fernández I.
    Pediatr Cardiol; 2019 Aug; 40(6):1165-1170. PubMed ID: 31175403
    [Abstract] [Full Text] [Related]

  • 36. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD, Saunders AB, Gordon SG, Norby B, Miller MW.
    J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
    [Abstract] [Full Text] [Related]

  • 37. Lung ultrasound score has better diagnostic ability than NT-proBNP to predict moderate-severe bronchopulmonary dysplasia.
    Alonso-Ojembarrena A, Méndez-Abad P, Alonso-Quintela P, Zafra-Rodríguez P, Oulego-Erroz I, Lubián-López SP.
    Eur J Pediatr; 2022 Aug; 181(8):3013-3021. PubMed ID: 35648231
    [Abstract] [Full Text] [Related]

  • 38. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
    Slaughter JL, Reagan PB, Newman TB, Klebanoff MA.
    JAMA Pediatr; 2017 Mar 06; 171(3):e164354. PubMed ID: 28046188
    [Abstract] [Full Text] [Related]

  • 39. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia.
    König K, Guy KJ, Nold-Petry CA, Barfield CP, Walsh G, Drew SM, Veldman A, Nold MF, Casalaz DM.
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec 01; 311(6):L1076-L1081. PubMed ID: 27760764
    [Abstract] [Full Text] [Related]

  • 40. Predictive values of clinical data,molecular biomarkers, and echocardiographic measurements in preterm infants with bronchopulmonary dysplasia.
    Wang H, Yan D, Wu Z, Geng H, Zhu X, Zhu X.
    Front Pediatr; 2022 Dec 01; 10():1070858. PubMed ID: 36923947
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.